J Bacteriol, March 1998, p. 1119-1128, Vol. 180, No. 5
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Helicobacter pylori porCDAB and oorDABC
Genes Encode Distinct Pyruvate:Flavodoxin and
2-Oxoglutarate:Acceptor Oxidoreductases Which Mediate Electron
Transport to NADP
Nicky J.
Hughes,1
Chris L.
Clayton,2
Peter A.
Chalk,2 and
David
J.
Kelly1,*
Department of Molecular Biology and
Biotechnology, University of Sheffield, Sheffield S10
2TN,1 and
Glaxo-Wellcome Ltd.,
Stevenage, Herts SG1 2NY,2 United Kingdom
Received 4 September 1997/Accepted 17 December 1997
 |
ABSTRACT |
Helicobacter pylori, a major cause of human gastric
disease, is a microaerophilic bacterium that contains neither pyruvate nor 2-oxoglutarate dehydrogenase activity. Previous studies (N. J. Hughes, P. A. Chalk, C. L. Clayton, and D. J. Kelly, J. Bacteriol. 177:3953-3959, 1995) have indicated that the major routes
for the generation of acetyl coenzyme A (acetyl-CoA) and
succinyl-CoA are via pyruvate:flavodoxin oxidoreductase (POR) and
2-oxoglutarate:acceptor oxidoreductase (OOR), respectively. The
purified POR is a heterotetrameric protein, with subunits of
48 (PorA), 36 (PorB), 24 (PorC), and 14 (PorD) kDa. In this study OOR
has been purified, and it is similarly composed of
polypeptides of 43 (OorA), 33 (OorB), 24 (OorC), and 10 (OorD) kDa.
Both POR and OOR are oxygen labile and are likely to be major
contributors to the microaerophilic phenotype of H. pylori. Unlike POR, OOR was unable to use a previously identified
flavodoxin (FldA) as an electron acceptor. Although the purified
enzymes were unable to reduce NAD(P), electrons from both pyruvate and
2-oxoglutarate could reduce NADP in cell extracts, consistent with a
role for these oxidoreductases in the provision of NADPH as a
respiratory electron donor. The H. pylori por,
oor, and fldA genes were cloned and sequenced.
The deduced por gene products showed significant sequence
similarity to archaeal four-subunit 2-oxoacid:acceptor
oxidoreductases. However, the amino acid sequences of OorA and
-B were more closely related to that of the two-subunit POR of
the aerobic halophile Halobacterium halobium. Both
porD and oorD encode integral ferredoxin-like
subunits. POR and OOR are probably essential enzymes in H. pylori, as insertion inactivation of porB and
oorA appeared to be lethal.
 |
INTRODUCTION |
Helicobacter pylori is a
curved or spiral gram-negative, microaerophilic bacterium which is now
recognized as the major etiological agent in chronic active type B
gastritis. H. pylori infection is also strongly
associated with gastric and duodenal ulceration (42), and
long-term infection may predispose individuals to the development of
gastric carcinoma (15, 31). In the western world, about 30 to 50% of individuals may be infected with H. pylori,
making it among the most common infections in humans.
The physiology and metabolism of H. pylori are not well
understood. The bacterium possesses enzymes of the Entner-Doudoroff and
pentose-phosphate pathways (5, 29, 30), but although it is
capable of glucose metabolism, respiratory activity is greater with
some organic acids, such as pyruvate (6). Recently, it was
shown that in contrast to the usual pyruvate dehydrogenase complex
employed by aerobes, the main route for pyruvate assimilation in
H. pylori is via a pyruvate:flavodoxin oxidoreductase
(POR) (EC 1.2.7.1) (20). This enzyme was purified to
homogeneity and shown to belong to a newly recognized group of
four-subunit PORs. The in vivo electron acceptor of this enzyme is
likely to be an endogenous flavodoxin, which was partially purified and shown to be reduced by POR. A 2-oxoglutarate:acceptor oxidoreductase (OOR) activity (EC 1.2.7.3) has also been detected in H. pylori (19, 20), catalyzing the analogous, reversible
oxidative decarboxylation of 2-oxoglutarate to form succinyl coenzyme A
(succinyl-CoA), a major intermediate of the tricarboxylic acid (TCA)
cycle. OOR enzymes have been purified from a number of thermophilic
bacteria and archaea. The OOR enzyme of Thermococcus
litoralis is composed of four subunits, which have molecular
masses comparable to those of four-subunit POR enzymes (25),
whereas the OORs of Halobacterium halobium and
Hydrogenobacter thermophilus consist of two subunits of 88 and 36 kDa (21) and 70 and 35 kDa (45),
respectively. In an analogous fashion to POR, OOR enzymes catalyze the
reduction of low-potential electron acceptors, such as ferredoxins
(Fd), according to the following reaction:
2-oxoglutarate + CoA + Fdox
succinyl-CoA + CO2 + Fdred
The presence of these 2-oxoacid:acceptor oxidoreductases
in H. pylori is of importance for several reasons.
First, unlike the 2-oxoacid dehydrogenase multienzyme complexes, these
enzymes are highly oxygen labile. This may at least partly explain the microaerophilic nature of H. pylori. Second, POR has
been demonstrated to be involved in the reduction of metronidazole
(20), a drug commonly used in H. pylori
eradication regimes. The reduction of the drug's nitro group is
essential to generate various short-lived derivatives capable of
causing DNA damage (see reference 14 for review).
Metronidazole resistance in H. pylori isolates is commonly observed (16, 17), but the molecular basis for
resistance is unclear. Hoffman et al. (19) have reported
complex metabolic changes in metronidazole-resistant mutants of
H. pylori, including an apparent repression of POR
activity. More recently, Smith and Edwards (38) reported
that oxygen scavenging is compromised in resistant strains, as isogenic
mutants were found to possess approximately one-third the NADH oxidase
activity of wild-type strains. The resulting increase in intracellular
oxygen in resistant strains may thus prevent metronidazole activation
by increasing futile cycling to the inactive, oxidized form.
In anaerobic bacteria, the generation of low-potential reductants, such
as ferredoxin or flavodoxin, by POR or OOR can be utilized to power a
number of processes, including hydrogen evolution (2, 11)
and nitrogen fixation (4, 34, 35). In this paper, a role in
the provision of NADPH for respiratory electron transport in
H. pylori is proposed. We also report the purification of the H. pylori OOR enzyme; the cloning and
characterization of the por, oor, and
fldA genes of H. pylori NCTC 11637; and the expression of POR in Escherichia coli. This study also
allows definitive functions to be assigned to several genes identified in the recently released complete genome sequence of H. pylori 26695 (40).
 |
MATERIALS AND METHODS |
Enzymes and chemicals.
Restriction endonucleases were
purchased from Promega and MBI Fermentas. Recombinant Pyrococcus
furiosus DNA polymerase (Pfu) was obtained from
Stratagene. Hyperfilm MP and an L-U-14C-amino
acid mixture (1.85 to 2.2 GBq mmol
1) were obtained from
Amersham. All other chemicals were purchased from Sigma.
Bacterial strains.
H. pylori (NCTC 11637) was
obtained from the National Collection of Type Cultures, Colindale,
England. Helicobacter cinaedi, Helicobacter
nemestrinae, Helicobacter felis, Helicobacter
muridarium, Helicobacter acinonyx, Helicobacter
mustelae, Campylobacter jejuni, Campylobacter
coli, and H. pylori 4187E and 8091 were obtained from A. McClaren, Glaxo-Wellcome Ltd. Expression of H. pylori POR was carried out with the vector pET21a (Novagen), which
was propagated in E. coli XL-1 Blue (Stratagene). E. coli BL21(DE3) was used as the host strain for POR expression
studies.
Growth of bacterial strains.
All species of
Helicobacter were routinely cultivated under microaerobic
conditions (5% O2, 10% CO2, 85%
N2 [all vol/vol]) at 37°C on Columbia agar supplemented
with 5% (vol/vol) chocolated horse blood and 10 µg each of
amphotericin B, vancomycin, and polymyxin B ml
1. C. jejuni and C. coli were grown on the same medium except
that polymyxin B was omitted. For liquid culture, brain heart infusion (BHI) broth plus 5% (vol/vol) horse or fetal calf serum, supplemented with the antibiotics described above, was used.
POR and OOR assays.
Quantitative measurements of POR
activity were carried out with the artificial electron acceptor methyl
viologen, using the assay previously described (20). A
rapid-screening technique with 96-well microtiter plates was used to
detect OOR-containing fractions from purification experiments. Each
microtiter assay mixture contained the following: enzyme fraction, 100 to 200 µl; 1 M 2-oxoglutarate, 2 µl; 1 M methyl viologen, 1 µl;
and 100 mM CoA, 1 µl. The wells were covered with a layer of mineral
oil immediately after the addition of enzyme to aid in the exclusion of
oxygen. OOR-containing fractions rapidly turned blue, before being
reoxidized. The quantitative assay for OOR was carried out by a method
identical to that described for POR (20) but with 5 mM
pyruvate replaced by 5 mM 2-oxoglutarate.
Purification of H. pylori POR and partial
purification of flavodoxin FldA.
Purification of POR and partial
purification of FldA were performed as previously described
(20).
Partial purification of OOR.
In the following protocol, the
column chromatography was carried out in air, but the exposure of the
enzyme to oxygen was reduced by flushing all buffers with
N2 prior to use and transferring all purification fractions
and enzyme extracts immediately into vessels also flushed with
N2. For the small-scale purification of H. pylori OOR, 1.4 g (wet weight) of NCTC 11637 cells, grown in
BHI broth under microaerobic conditions, was resuspended in 5 ml of 10 mM Tris-HCl (pH 8.0)-1 mM dithiothreitol. The cells were sonicated
(three cycles of 15 s) and centrifuged for 30 min at 100,000 × g at 4°C. The supernatant was loaded onto a MonoQ HR5/5
ion-exchange column (Pharmacia) preequilibrated in 50 mM Tris-HCl (pH
8.0)-1 mM dithiothreitol (buffer A). The column was washed with 10 column volumes of buffer A plus 50 mM KCl. The activity was eluted with
an increasing linear gradient of KCl from 50 to 250 mM over 15 column
volumes. Active fractions were pooled and brought to 1.5 M ammonium
sulfate. The sample was then loaded onto a phenyl-Superose HR5/5 column
(Pharmacia) equilibrated with 1.5 M ammonium sulfate in buffer A, and
any unbound protein was removed by washing with 5 column volumes. The
column was developed with a decreasing linear gradient of ammonium
sulfate from 1.5 to 0.75 M over 30 column volumes. Active fractions
were examined by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). For N-terminal sequencing, proteins were
separated on an SDS-12% polyacrylamide gel, electroblotted onto a
polyvinylidene difluoride membrane, and stained with amido black, and
individual bands were excised for N-terminal sequencing by the
automated Edman degradation procedure.
Substrate oxidation by H. pylori sonicated cells
and membrane fractions.
For respiration studies, 500 ml of BHI
broth was inoculated with H. pylori NCTC 11637 and
grown under microaerobic conditions with gentle agitation for 24 h. Cells were harvested at 8,000 × g for 15 min at
4°C, washed once in 20 mM phosphate buffer (pH 7.0), and resuspended
in a small volume of the same buffer. Cells were lysed by sonication,
and cell debris and unbroken cells were removed by centrifugation at
13,000 × g for 20 min at 4°C. The cell extract was
then stored on ice for use the same day. Membranes were prepared by
centrifugation of the cell extract (150,000 × g,
2 h, 4°C), and the pelleted membranes were resuspended in
phosphate buffer. Substrate oxidation was determined by measuring
changes in the dissolved oxygen concentrations in a Clarke-type oxygen electrode calibrated with air-saturated 20 mM potassium phosphate buffer, pH 7.0 (219 nmol of dissolved O2 ml
1
at 37°C). Baselines were determined by reducing all dissolved oxygen
with excess sodium dithionite. Cell or membrane suspensions were
maintained at 37°C and stirred at a constant rate.
Isolation and manipulation of DNA.
Helicobacter and
Campylobacter genomic DNAs were isolated by the
method described by Majewski and Goodwin (27). Plasmid DNAs
were purified with the Qiagen Plasmid Midi Kit. All standard molecular
biology protocols were carried out as described by Sambrook et al.
(33).
Detection of heterologous por and oor
genes.
Southern blotting was carried out by using digoxigenin
labeling and chemiluminescence detection according to the instructions of the manufacturer (Boehringer Mannheim). Genomic DNAs were digested overnight with HindIII, and the fragments were separated
on a 0.7% (wt/vol) agarose gel and blotted onto a nylon membrane
(Hybond N; Amersham). Hybridization with digoxigenin-labeled
porA and oorB probes and high-stringency washes
(0.1% [vol/vol] SSC, 0.1% [wt/vol] SDS) were performed at 68°C.
DNA sequencing.
Sequencing was carried out by the
Perkin-Elmer Dye Terminator method. Sequence analysis was carried out
with the Wisconsin Genetics Computer Group package. Random
H. pylori NCTC 11637 sequences were generated from
genomic DNA which was sonicated and partially digested with
four base cutter restriction enzymes. Fragments were then cloned into
pBluescript (Stratagene) prior to sequencing with T7 and T3 primers.
The gridded H. pylori NCTC 11637 plasmid library was
generated by partial digestion of genomic DNA with Sau3A to generate fragments with an average size of 4 kb.
Fragments were cloned into pUC18, and E. coli TG1 was
transformed with the library. Six thousand recombinants, corresponding
to a 14-fold representation of the genome, were then gridded onto
Hybond N (Amersham) membranes in preparation for probing.
Expression of H. pylori POR in E. coli.
Primers were designed to introduce an NdeI
restriction site (underlined) at the porC start codon
(5'-ACGTCATATGTTTCAAATTAGATGGCATGCA-3') and
a BamHI site in a sequence downstream of the 3' end of
porB (5'-ACGTGGATCCTGGTTTGCTCATTCCATAGGGCTT-3'). PCR
was carried out on H. pylori (NCTC 11637)
genomic DNA with Pfu DNA polymerase on a
Perkin-Elmer DNA Thermal Cycler 480 (25 cycles of denaturation for 1 min at 94°C, annealing for 1 min at 45°C, and extension for 4 min
at 72°C). The 3.4-kb PCR product was ligated into
NdeI/BamHI-restricted pET21a to generate plasmid
pNJH301, which was ultimately transformed into E. coli
BL21(DE3). For expression, BL21(DE3, pNJH301) cells were
grown aerobically in Luria-Bertani medium with 100 µg of ampicillin
ml
1 to mid-exponential phase. The cells were harvested,
washed once in M9 medium (33), resuspended in M9 plus 0.2%
glucose, and grown aerobically with shaking for 90 min. IPTG
(isopropyl-
-D-thiogalactopyranoside) (1 mM) was then
added, and the culture was incubated for a further 90 min in a
microaerobic atmosphere (5% O2, 10% CO2, 85%
N2 [vol/vol]), or in air in order to test expression
under aerobic conditions. Rifampin was then added to a final
concentration of 200 µg ml
1, and the incubation was
continued for a further 90 min under microaerobic conditions. The cells
were then harvested by centrifugation and resuspended in 2 ml of buffer
A. All buffers and vessels used to store the enzyme were flushed with
N2 prior to being sealed to reduce exposure of the enzyme
to oxygen. The cell suspension was then sonicated (five times for
15 s each), an oxygen-scavenging system (0.1 U of catalase, 3 U of
glucose oxidase, and 0.4% [wt/vol] glucose) was added, and after
centrifugation (14,000 × g, 10 min, 4°C) the
supernatant was collected and stored in screw-cap tubes on ice prior to
assaying.
Radiolabeling of proteins expressed from pNJH301.
The
cells were propagated as described above, except that aerobic
conditions were used throughout. After the incubation in the presence
of rifampin, 1 µCi of a 14C-amino acid mixture was added
to the cell suspension and incubated aerobically at 37°C for 2 h. Yeast extract was then added to give a final concentration of 0.1%
(wt/vol), the cells were harvested, and a cell extract was prepared as
described above. Approximately 10 µg of cell extract protein was used
for SDS-PAGE analysis. Following electrophoresis, the gel was stained
with Coomassie blue, destained and soaked in Amplify (Amersham), and
then vacuum dried and exposed to Hyperfilm MP (Amersham) for 72 h
at
70°C.
Insertion inactivation of por and oor
genes.
Plasmid pAL21 contained a 774-bp insert cloned into
pBluescript, of which 753 bp was the 5' end of the porB
gene. A 0.7-kb DNA fragment encoding the chloramphenicol
acetyltransferase gene from C. coli (43) was
ligated into a unique NcoI site in porB, flanked
by 183 and 585 bp of insert DNA on either side, to give pAL21R. The
pUC18-based plasmid construct pNJH4B9S contained a 1.35-kb
SphI fragment encoding the 3' end of oorA and the
5' end of oorB. A 1.1-kb PCR-derived kanamycin resistance
cassette containing the aphIII gene from C. coli
(41) was ligated into a unique NcoI site in
oorA in pNJH4B9S to give pNJH4B9SK. The
chloramphenicol acetyltransferase cassette described above was also
ligated into a unique MscI site in oorA to give
plasmid pNJH4B9SC. The plasmids pAL21R, pNJH4B9SK, and
pNJH4B9SC were then introduced into H. pylori NCTC
11637 by natural transformation according to the following protocol.
Ten milliliters of BHI broth plus serum and antibiotics was inoculated
with H. pylori and grown overnight. The culture was
then diluted to give a starting optical density at 710 nm of
approximately 0.1 U and allowed to grow for a further 8 h. Plasmid
DNA (2 µg) was then added to 1 ml of this culture and incubated
overnight with agitation in a microaerobic atmosphere. The cells were
then pelleted, resuspended in 100 µl of BHI, and spread onto Columbia
agar supplemented with horse blood, the standard antibiotics listed
above, and either 30 µg of chloramphenicol ml
1 or 50 µg of kanamycin ml
1 to select for mutants arising by
homologous recombination. The resulting agar plates were grown for 1 week and then examined for the appearance of resistant colonies.
Nucleotide sequence accession numbers.
The nucleotide
sequences of the H. pylori por, oor, and
fldA genes have been submitted to the GenBank/EMBL data bank
and assigned accession numbers AF021092, AF021094, and AF021093,
respectively.
 |
RESULTS |
Partial purification and N-terminal sequencing of the H. pylori OOR.
Cell extracts of H. pylori
contain both pyruvate- and 2-oxoglutarate-dependent oxidoreductase
activities, which are capable of reducing low-potential artificial
electron acceptors (19, 20). As previous work had shown that
the purified H. pylori POR enzyme was specific for
pyruvate decarboxylation (20), the 2-oxoglutarate activity
must be due to a separate enzyme. This activity was partially purified
by using a two-step procedure involving ion-exchange chromatography on
MonoQ (Pharmacia) and hydrophobic interaction chromatography on
phenyl-Superose (Pharmacia). This resulted in a greater-than-60-fold
increase in specific OOR activity but yielded less than 5% of the
original activity (Table 1). The low
yield was most likely due to the inevitable exposure of the enzyme to
O2 during purification. With cell extract stored anaerobically on ice for 24 h, the addition of 1 mM thiamine
pyrophosphate (TPP) to the standard OOR assay mixture increased OOR
activity by 133%. However, the addition of TPP failed to stimulate the POR activity of this extract. Thus, the low yield may also be influenced by the leaching of TPP from the native OOR enzyme complex. OOR activity eluted from the MonoQ column at 0.15 M NaCl, just ahead of
POR, which eluted at 0.19 M NaCl. The OOR enzyme was extremely unstable
and could not be further purified by gel filtration chromatography
without a complete loss of activity. The purified preparation retained
OOR activity for only approximately 12 h when stored on ice under
anaerobic conditions and was completely inactivated after freezing to
20 or
70°C. The omission of dithiothreitol from chromatography
buffers and the exposure of the cell extract to oxygen for extended
periods also resulted in inactivation of the enzyme.
SDS-PAGE analysis revealed the presence of six major
polypeptides in the purified OOR preparation, with molecular
masses of 65, 43, 33, 28, 21, and 10 kDa (Fig.
1). N-terminal sequences were obtained
for all of these proteins (Table 2). The
enzyme preparation was found to contain low levels of urease activity, and the presence of the contaminating urease A (65-kDa) and B (28-kDa)
subunits was confirmed by comparison of their N-terminal sequences to
those previously published for the H. pylori urease enzyme (12). The 43-, 33-, 21-, and 10-kDa
polypeptides represented the four subunits of the OOR enzyme
(see below) and were designated OorA, OorB, OorC, and OorD
respectively.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-PAGE analysis of partially purified H. pylori OOR. Lanes A and B show two fractions resulting from the
final phenyl-Superose (Pharmacia) chromatography step in the
H. pylori OOR purification protocol. The proteins were
separated on an SDS-12% polyacrylamide gel and detected by silver
staining. Six major bands with molecular masses of 65, 43, 33, 28, 21, and 10 kDa (arrows) were detected. The 28- and 65-kDa bands were
determined by N-terminal sequence analysis to be the urease A and B
subunits, respectively. The remaining four bands, with molecular masses
of 43, 33, 21, and 10 kDa, represent the OorA, -B, -C, and -D subunits,
respectively.
|
|
Analysis of OOR activity and identification of pyruvate- and
2-oxoglutarate-dependent NADP reduction in cell extracts.
The
partially purified OOR enzyme was tested for its dependency on various
components of the OOR assay mixture. In the presence of 0.1 mM CoA and
5 mM 2-oxoglutarate, the specific activity of the enzyme was 0.925 µmol of methyl viologen reduced min
1 mg of
protein
1 (Table 1). The omission of either 2-oxoglutarate
or CoA from the reaction mixture, or the replacement of 5 mM
2-oxoglutarate with 5 mM pyruvate, completely prevented the reduction
of methyl viologen. Thus, in H. pylori OOR specifically
catalyzes the oxidative decarboxylation of 2-oxoglutarate, and POR
catalyzes solely the oxidative decarboxylation of pyruvate. As has also
been found with other 2-oxoacid oxidoreductases, the partially purified
OOR preparation could not utilize NAD or NADP as an electron acceptor when NAD or NADP was added to the complete reaction mixture in place of
methyl viologen.
Km values for the substrates of both the POR and
OOR activities in cell extracts were determined. The
Km values of POR and OOR for pyruvate and
2-oxoglutarate were 0.222 and 0.309 mM, respectively. Interestingly,
the affinity of the POR enzyme for CoA was found to be much higher than
that of the OOR enzyme, with respective Km
values of 1.97 and 13.3 µM.
Earlier studies have shown that the in vivo electron acceptor for POR
in H. pylori is likely to be a flavodoxin
(20). To determine whether this flavodoxin acted as an
electron acceptor for the OOR enzyme, a MonoQ fraction containing both
POR and OOR activities was incubated anaerobically with CoA and the
H. pylori flavodoxin, which was purified as previously
described (20). 2-Oxoglutarate was then added, and the
reduction of the flavodoxin was monitored at 452 nm (Fig.
2). No reduction was observed in the
presence of 2-oxoglutarate. However, following the addition of
pyruvate, a rapid quenching of absorption at 452 nm was observed, indicating that only the POR enzyme reduced the flavodoxin. Attempts were made to identify other ferredoxin and flavodoxin proteins by
fractionating H. pylori cytoplasmic proteins by MonoQ
ion-exchange chromatography. The resulting fractions were then scanned
for the characteristic absorption spectra of ferredoxins and
flavodoxins. However, we were not able to identify a candidate
low-potential electron acceptor for the OOR enzyme.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
A flavodoxin (FldA) acts as an electron acceptor for the
POR enzyme but not for OOR. A MonoQ-purified fraction of H. pylori cell extract, containing both POR and OOR activities, was
incubated initially in the presence of sufficient partially purified
H. pylori flavodoxin (20) to give a starting
absorbance of 0.06 (at 452 nm) and 0.1 mM CoA under anaerobic
conditions. The background rate for the reduction of the flavodoxin
protein was monitored at 452 nm. 2-Oxoglutarate (5 mM) was then added
anaerobically to the cuvette. No increase in the rate of flavodoxin
reduction was observed in the presence of this substrate. However,
following the addition of 5 mM pyruvate, reduction proceeded rapidly,
indicating that the isolated flavodoxin was specifically reduced by
electrons derived from the POR reaction.
|
|
As expected, the purified POR and OOR were unable to utilize NAD or
NADP as an electron acceptor, but a CoA- and pyruvate- or
2-oxoglutarate-dependent reduction of NADP could be demonstrated in
cell extracts incubated under anaerobic conditions (Fig.
3). No activity was observed with NAD as
the electron acceptor, and the NADP reductase activity was completely
abolished under aerobic assay conditions, suggesting that pyruvate or
2-oxoglutarate dehydrogenase activities, which are commonly assayed
under aerobic conditions, were not active in the cell extract. Further
evidence that 2-oxoacid dehydrogenases are not present in H. pylori has been provided by the complete genome sequence of strain
26695, which lacks homologs of these genes (40).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
Pyruvate- and 2-oxoglutarate-dependent reduction of NADP
by H. pylori cell extract. The pyruvate (A)- and
2-oxoglutarate (B)- and CoA-dependent reduction of NADP by
H. pylori cell extract, under anaerobic conditions, is
shown. The assays were carried out in a 2-ml volume, and the assay
mixtures contained 5 mM 2-oxoglutarate or pyruvate, 0.1 mM CoA, 100 µl of H. pylori cell extract, and 1 mM NADP. The
point of 2-oxoacid addition is indicated. The effect of pyruvate or
2-oxoglutarate addition on NADP reduction is indicated by the dashed
line. The rate of NADP reduction under aerobic conditions is indicated
by the solid line, and the rate of NAD reduction, added in place of
NADP, is indicated by the dashed and dotted line. Reduction of NADP was
observed in the presence of both pyruvate and 2-oxoglutarate and was
dependent on anaerobic conditions. Furthermore, NADP could not be
replaced by NAD.
|
|
NADPH is used in preference to NADH as a respiratory electron donor
in H. pylori.
Since the experiments described above
showed that electrons derived from the POR and OOR reactions
preferentially mediate the reduction of NADP, oxygen uptake by
H. pylori in the presence of NADPH and NADH was
examined. In most bacteria, NADH acts as the major electron donor for
respiration. However, Table 3 shows that
membrane preparations of H. pylori, which typically
catalyze both succinate and ascorbate/TMPD
(tetramethyl-1,4-phenylenediaminedihydrochloride) oxidase
activities, did not exhibit detectable rates of oxygen uptake with NADH
as the electron donor. However, NADPH-dependent respiration was easily
measurable, implying that this is a major respiratory electron donor in
H. pylori in vivo. Cell extracts exhibited both
activities, presumably due to the presence of additional (soluble)
dehydrogenases.
Cloning, sequencing, and organization of the H. pylori
por and oor genes.
The N-terminal sequences
previously published for the four POR subunits (20) and
those reported above for OOR were compared with the translations of the
random genomic DNA sequences obtained in the Glaxo-Wellcome
H. pylori NCTC 11637 sequencing project (8).
The 38-residue N-terminal sequence of PorB was identified in the
translation of one of the reading frames of the 774-bp insert in
plasmid pAL21. The insert in pAL21 was then used as a hybridization
probe to screen the H. pylori pUC18 plasmid library in
order to obtain clones with larger inserts. This resulted in the identification of two plasmids, pNJHC233 (5.0-kb
insert) and pNJHG87 (4.5-kb insert), which were used to sequence a
4,373-bp region containing all four por genes (Fig.
4). A similar approach with the N termini
of the OOR subunits resulted in the identification of three plasmids
containing the oor genes. The plasmids pNJH1610D (6.0-kb
insert), pNJH99G (8.3-kb insert), and pNJH1116C (6.0-kb insert)
were used to obtain the complete sequence of a 3,350-bp region which
encompassed the oor genes (Fig. 4).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 4.
Organization of H. pylori por and
oor genes. A graphical representation of the oor
and por operons of H. pylori NCTC 11637 is
shown. Also indicated are the regions covered by plasmids used in this
study and the positions of insertion of kanamycin (Kmr) and
chloramphenicol (Cmr) resistance cassettes for inactivation
studies.
|
|
In each of these separate sequenced regions, four adjacent and complete
open reading frames (ORFs) were identified which displayed appropriate
H. pylori codon usage. The eight ORFs were
unequivocally identified as the genes encoding the subunits of POR and
OOR by concordance between the N-terminal amino acid sequences
determined for each of the POR and OOR subunits and those deduced
from the DNA sequence analysis.
The por genes are arranged in the order
5'-porC-porD-porA-porB-3'. A partially sequenced fifth ORF,
the product of which was 42% identical over 161 residues with the
adenylosuccinate lyase enzyme (PurB) of Bacillus subtilis
(13), was located 70 bp downstream of porB and
was designated purB. This enzyme plays a role in purine biosynthesis, an activity apparently unrelated to the POR enzyme. Each
of the ORFs was preceded by potential Shine-Dalgarno sequences, and the
properties of the deduced products are shown in Table 4. The oor genes are arranged
in the order 5'-oorD-oorA-oorB-oorC-3', again preceded by
potential Shine-Dalgarno sequences. Translational coupling was observed
between oorD and oorA and between oorB
and oorC (a TAATG motif in each case). Table 4 also shows
the properties of the oor genes and their deduced products.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Characteristics of the H. pylori oor and
por initiation and termination sites and predicted
gene products
|
|
Recently the complete genome sequence of H. pylori 26695 has become available (40). Examination of
this genome has confirmed the presence of homologous porCDAB
and oorDABC operons. The HP numbers assigned to
each of the individual genes are HP1108 to -1111 for the por
operon and HP0588 to -0591 for the oor operon. The
nucleotide sequences of the por and oor multigene
regions have also been entered under GenBank accession numbers AE000617 and AE000572, respectively. The gene order is identical in each operon,
and the purB gene, located downstream of the por genes in H. pylori 11637, is also found downstream of
the por genes in strain 26695. The percent identities
between the predicted por and oor gene products
of strains 11637 and 26695 are as follows (the number of amino acids
aligning is given in parentheses): PorD, 100 (129); PorC, 98 (164); PorB, 100 (314); PorA, 95 (408); OorD, 98 (113); OorC, 97 (183); OorB, 97 (274); and OorA, 96 (374).
Identification of por and oor homologs in
other Helicobacter strains.
Genomic DNA preparations
of bacteria closely related to H. pylori were screened
by Southern blotting for hybridization to porA and
oorB genes. With the high-stringency conditions described in
Materials and Methods, both probes hybridized with DNA from H. acinonyx, H. felis, and
H. pylori NCTC 11637, 4187E, and 8091. Under the same
conditions, no hybridization was detected with H. muridarum or H. mustelae (results not shown).
Although POR activity has been observed in many
Campylobacter species, including C. jejuni and
C. coli (9), Southern blotting with
genomic DNAs from these two species failed to detect homologous
sequences under the conditions described (results not shown),
indicating a greater divergence in sequence.
Amino acid sequence similarities and identification of potential
TPP- and cation-binding sites and iron-sulfur centers in the deduced
proteins.
Surprisingly, although POR and OOR of H. pylori are biochemically similar enzymes, each composed of four
subunits, BESTFIT alignments of the amino acid sequences of the
corresponding polypeptides revealed a fairly low overall level
of identity: PorA-OorA, 25.0%; PorB-OorB, 18.9%; PorC-OorC, 23.3%,
and PorD-OorD, 20.6%. FASTA database searches clearly showed that POR
of H. pylori is most closely related to the recently
recognized group of four-subunit PORs from hyperthermophiles
(22). Each H. pylori POR subunit sequence
displayed the most similarity to its corresponding subunit from
the Thermotoga maritima and P. furiosus enzymes
(between 38.1 and 44.2% identities). The subunit sequences could
also clearly be aligned with corresponding domains in single-subunit
PORs, as has previously been reported with the P. furiosus
and T. maritima POR sequences and the closely related
P. furiosus ketoisovalerate:ferredoxin oxidoreductase enzyme
(22).
All PORs isolated to date contain the cofactor TPP. A conserved
sequence motif (GD/QG-X25-30-NN) has been identified for
TPP binding (18). Similar motifs have also been identified in both PorB and OorB (Fig. 5A and B).
This motif is part of a highly conserved region in all PORs, but due to
insufficient amounts of the purified H. pylori enzymes,
we have not been able to perform biochemical analyses to confirm the
presence of TPP. PorB and OorB contain vicinal cysteines
(C-X2-C), which are also present in other PORs. This motif
has been proposed to play a role in heavy metal cation binding
(37).

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 5.
Alignments of predicted TPP- and Fe-S-binding sites in
H. pylori POR, OOR, and related enzymes. (A and B)
PileUp alignments indicating putative conserved regions for TPP binding
based on the consensus motif proposed by Hawkins et al. (18)
in the H. pylori PorB subunit and related enzymes (A)
and in the H. pylori OorB subunit and
Halobacterium halobium PorB subunits (B). (C) Regions of
conservation-associated Fe-S-binding sites found in the d subunits and
regions of 2-oxoacid oxidoreductases. The pattern of cysteine residues,
marked with asterisks, is typical of that found in bacterial
ferredoxins (39). Residues conserved in >50% of the
organisms are indicated by black boxes. The position of the first amino
acid in each alignment is also indicated. Abbreviations (accession
numbers are given in parentheses: Pf Vor (b) and (d), P. furiosus isoketovalerate:ferredoxin oxidoreductase B and D
subunits (X85250); Pf Por (b) and (d), P. furiosus
pyruvate:ferredoxin oxidoreductase B and D subunits (X85250); Tm Por
(b) and (d), T. maritima pyruvate:ferredoxin oxidoreductase
B and D subunits (X85171); Hp Por (b) and (d), H. pylori PorB and PorD (this study); Hp Oor (b) and (d),
H. pylori OorB and OorD (this study); Ha.h
Por (b), Halobacterium halobium pyruvate:ferredoxin
oxidoreductase B subunit (X64521); K. pneu, K. pneumoniae
NifJ (X13109); En. agg, Enterobacter agglomerans NifJ
(X78558); Anab., Anabeana sp. strain PCC 7120 (L14925); R. rub, Rhodospirillum rubrum pyruvate oxidoreductase (X77515);
Ea. his, Entamoeba histolytica pyruvate oxidoreductase
(U30149); T. vag, Trichomonas vaginalis pyruvate:ferredoxin
oxidoreductase (U16822); G. int, Giardia intestinalis POR
(L27221).
|
|
Interestingly, the H. pylori OorA and OorB sequences
are far more closely related to those of the
and
subunits,
respectively, of the two-subunit Halobacterium halobium
pyruvate:ferredoxin oxidoreductase (21, 32) than to the PorA
and -B subunits of the hyperthermophiles. H. pylori
OorA displays 31.8% identity over 385 amino acids to the
Halobacterium halobium
subunit, in comparison to only
20.2% over 387 amino acids for the PorA subunit of P. furiosus.
H. pylori OorB displays 37.5% amino acid identity to the
Halobacterium halobium B subunit over 175 residues. The
amino acid sequences of OorC and OorD are most closely related to those
of P. furiosus OorC (26% identity over 177 residues) and
Anabaena variabilis ferredoxin (35.4% identity over 65 residues). Sequences similar to those of OorD, -A, -B, and -C have also
been identified in the genome sequence of Methanococcus
jannaschii (accession number U67482). However, the gene order is
different in this organism (C-D-A-B), and to the best of our
knowledge, this enzyme has not been purified and thus its substrate
specificity is unknown.
Most bacterial-type ferredoxins possess two cysteine-rich sequences,
each of which conforms to the consensus
(-C-X2-C-X2-C-X3-C-) (39). The two units are separated by a connector region of
variable length and cooperate to form two [4Fe-4S] centers. This
consensus is clearly present in both PorD and OorD and in the D
subunits and domains of other POR enzymes (Fig. 5C). The exception to
this is the Halobacterium halobium POR enzyme, which
contains only one such cysteine-rich unit (32). The
iron-sulfur compositions of the H. pylori POR and OOR
enzymes could not be determined due to insufficient amounts of purified
enzyme. However, from the amino acid sequence it would appear that the
enzymes contain at least two [4Fe-4S] clusters per molecule, and this
composition has also been found in the four-subunit enzymes of
P. furiosus (1), T. maritima
(2), and Methanococcus maripaludis
(44).
Expression of H. pylori POR in E. coli.
In order to further examine the oxygen lability of the POR enzyme in a
heterologous background, the porCDAB operon was PCR amplified with primers designed to introduce an NdeI site
into the start codon of porC, and the product was cloned
into the translation initiation site of pET21a to give pNJH301.
Expression from the plasmid was examined by radiolabeling of the
IPTG-induced translation products. Four polypeptides of the
correct molecular masses for the porA, -B,
-C, and -D gene products were produced after
induction of E. coli BL21(DE3, pNJH301) (results not
shown). A significant increase in POR activity was also detected in
cell extracts (Table 5) prepared from
cells which had been induced under microaerobic conditions in M9
medium. No active enzyme was obtained if the cells were induced under
aerobic conditions. The background activity observed in the control
strain is due to a low endogenous activity of pyruvate oxidoreductase
apparently constitutively expressed in E. coli
(3).
Insertion inactivation of H. pylori porB and
oorA.
Plasmids pAL21R, pNJH4B9SK, and pNJH4B9SC were
used for natural transformation of H. pylori NCTC 11637 in attempts to obtain chromosomal null mutants of either
porB or oorA by allelic exchange. No
antibiotic-resistant colonies (<10
9 per CFU) were
obtained with any of these constructs. As a control for the insertion
inactivation procedure, a plasmid containing a null mutation in a known
nonessential chemotaxis gene (cheY) was used. In this
plasmid the chloramphenicol resistance gene was flanked by 109 and 953 bp of H. pylori DNA. Transformation with this plasmid
yielded chloramphenicol-resistant colonies at a frequency of 2.6 × 10
5 per CFU. Several of these colonies were selected
and shown to contain a disrupted chromosomal cheY gene by
PCR (data not shown). The lack of colonies with the por and
oor constructs therefore suggests that these are essential
genes in H. pylori.
Identification of the structural gene (fldA) of the
H. pylori POR-specific flavodoxin.
Partial
purification of the POR-specific flavodoxin from H. pylori has been reported previously (20). SDS-PAGE
analysis indicated that the resulting purification fraction contained a major protein of 17 kDa, a molecular mass similar to those of other
flavodoxins (results not shown). The N-terminal sequence for the
excised band was determined to be -GKIGIFFGT-. A comparison of this
sequence with translations of the Glaxo-Wellcome H. pylori NCTC 11637 random-sequence database (8)
identified a plasmid encoding 400 bp of the fldA gene. The
insert was used to screen the H. pylori plasmid library
to identify a plasmid, pKB1, from which a 1,004-bp region of DNA was
sequenced. The region contains the structural gene for this flavodoxin,
which was confirmed by concordance between the N-terminal sequence of
the isolated protein and the predicted amino acid translation.
fldA encodes a protein of 173 amino acids with a predicted
molecular mass and pI of 18.37 kDa and 4.46, respectively. The low pI
value and the predominance of acidic residues in comparison to basic
residues (21 versus 11%) are typical features of other flavodoxins
(28). A homologous fldA sequence is also present
in the genome sequence of H. pylori 26695 (HP gene
number 1161, accession number AE000622) (40). The predicted
amino acid sequences of the two flavodoxins are 92% identical over 163 amino acid residues.
 |
DISCUSSION |
Previous biochemical studies have emphasized the importance of
2-oxoacid oxidoreductases in the generation of acylthioesters in
H. pylori (19, 20). The genome sequence of
strain 26695 has supported these assertions, as homologs of pyruvate
dehydrogenase, 2-oxoglutarate dehydrogenase, and pyruvate:formate lyase
genes have not been identified. This paper produces evidence for a
second essential acceptor:oxidoreductase in H. pylori,
which catalyzes the specific oxidative decarboxylation of
2-oxoglutarate. The end product of this reaction, succinyl-CoA, is a
major intermediate of the TCA cycle. However, enzymatic analysis has
shown that the cycle is incomplete in H. pylori, and in
particular, succinate thiokinase activity has not been detected
(9a). Homologs of succinate thiokinase genes also could not
be identified in the published genome sequence of strain 26695 (40). So what is the likely fate of succinyl-CoA in
H. pylori? Succinyl-CoA is required for lysine
biosynthesis in the tetrahydrodipicolinate N-succinyl transferase reaction, and a homolog of this enzyme has been identified in the genome sequence (40). A gene for a putative
3-oxoadipate-CoA transferase has also been identified. This enzyme
catalyzes the conversion of succinyl-CoA and 3-oxoadipate to succinate
and 3-oxoadipyl-CoA, a reaction of the 3-oxoadipate pathway of aromatic
compound degradation. However, the importance of these pathways in the
growth of H. pylori is unknown.
Four types of 2-oxoacid oxidoreductases can be distinguished, based on
subunit structure and sequence similarities. The most ancient appear to
be the four-subunit enzymes typical of a number of thermophilic archaea
and bacteria, notably P. furiosus (1), Archaeoglobus fulgidus (24), and T. maritima (2). P. furiosus also possesses a
two-subunit indolepyruvate:ferredoxin oxidoreductase (23,
36). The 71-kDa
subunit of this enzyme possesses domains similar to the A, B, and the ferredoxin-like D domains described for
four-subunit 2-oxoacid oxidoreductases. Halobacterium
halobium also contains a two-subunit POR, which in contrast lacks
a distinctive ferredoxin-like subunit or domain (32).
Finally, single-subunit enzymes are typified by the NifJ proteins of
Klebsiella pneumoniae (4) and Anabaena
(35) and consist of four domains which have probably arisen
as a result of gene fusion events from an ancestral four-subunit enzyme
(22). This study has shown that although they are similar in
overall composition and properties, the two H. pylori four-subunit enzymes are not closely related to each other
in sequence but instead appear to have evolved independently. The
H. pylori POR shows greatest sequence similarity to
that of P. furiosus, while the H. pylori
OorA and OorB subunits are highly similar in amino acid sequence to the
Halobacterium halobium two-subunit POR.
The fact that H. pylori possesses 2-oxoacid
oxidoreductases, rather than the more usual dehydrogenase complexes
found in aerobes, has a number of consequences for the physiology of
this bacterium. First, it is clear that in their purified form they are
very oxygen labile, and they are no different in this respect from the
corresponding enzymes purified from obligate anaerobes. Expression of
the porCDAB genes in E. coli resulted in the
formation of an active enzyme only when the cells were induced under
reduced oxygen concentrations. The possession of these important
enzymes may thus contribute significantly to the observed
microaerophilic phenotype of H. pylori. Indeed, the
failure of attempts to insertionally inactivate the cognate genes would
indicate that both POR and OOR are essential for viability, and thus
their inhibition by oxygen could be potentially lethal. However,
because the bacterium has a respiratory metabolism, it seems likely
that there is some form of protection in vivo which, for example, could
maintain a low intracellular oxygen concentration and allow the enzymes
to operate satisfactorily in vivo. Second, because the electrons
derived from oxidation of the 2-oxoacids are used to reduce a
low-potential acceptor, identified as a flavodoxin in the case of POR,
these electrons must be removed in order to achieve redox balance and
to regenerate the oxidized acceptor. In many anaerobes, which contain
ferredoxin-linked 2-oxoacid oxidoreductases, the substrate-derived
electrons are disposed of through the evolution of hydrogen gas via the
hydrogenase enzyme. H. pylori contains hydrogenase
activity (10, 26) which appears to function as an uptake
hydrogenase, although its physiological role is unclear. Under aerobic
or microaerobic conditions, the evolution of hydrogen would be
thermodynamically unfavorable. In this study, we have provided evidence
that 2-oxoacid and CoA-dependent NADP reduction can occur in cell
extracts, i.e., in the presence of flavodoxin in the case of POR and an
as-yet-unidentified electron acceptor in the case of OOR, acting as
intermediate electron acceptors. The finding that the overall reaction
is specific for NADP rather than NAD is significant in view of the
observation that NADPH and not NADH is the most effective electron
donor to the respiratory chain, a conclusion which has also been
reached in other studies (6, 7). We therefore propose an
indirect role for POR and OOR in energy conservation in H. pylori by the provision of NADPH, as illustrated in Fig.
6. We assume that a flavodoxin and/or
ferredoxin:NADP oxidoreductase, which links 2-oxoacid oxidation to NADP
reduction, is active in H. pylori, but this remains to
be identified biochemically. Interestingly, a putative NAD(P)H:flavin
oxidoreductase gene has been identified in the genome sequence of
H. pylori 26695 (40). Future studies will
ascertain the physiological role of this candidate enzyme.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 6.
Proposed pathway for electron flow to NADP from reduced
flavodoxin in H. pylori. The proposed flow of electrons
generated in the POR reaction from flavodoxin is shown. The reduced
flavodoxin in turn donates electrons to NADP via a hypothetical
NADP:flavodoxin oxidoreductase (FNO). NADPH then enters the
electron transport chain ([e.t.c.]). The acetyl-CoA generated in the
POR reaction may enter the reactions of the incomplete TCA cycle found
in H. pylori or may generate ATP by substrate level
phosphorylation, yielding acetate.
|
|
It should also be noted with regard to energy conservation that acetate
is a major product of the aerobic metabolism of pyruvate in
H. pylori (5), and thus ATP can also be
generated from acetyl-CoA by substrate level phosphorylation. Putative
genes for the enzymes responsible for this reaction,
phosphotransacetylase and acetate kinase, have been identified in the
genome sequence of H. pylori 26695 (40).
Finally, as POR and OOR have been implicated in the bioreduction of
nitroimidazole drugs, particularly metronidazole (19, 20), a
more detailed knowledge of the electron transport pathways leading from
these enzymes will be relevant to an understanding of the mechanisms of
metronidazole activation and resistance, which are at present
poorly characterized.
 |
ACKNOWLEDGMENTS |
This work has been funded by Glaxo-Wellcome Ltd. through a Glaxo
scholarship to N.J.H.
We thank N. Crocker for Applied Biosystems nucleotide sequencing, N. Freeman and A Moir for N-terminal sequencing, A. McClaren for provision
of bacterial strains, K. Broughton for completion of the flavodoxin
sequence, and C. Jackson for the gift of the CheY-chloramphenicol
construct. We also thank A. A. Davison for carrying out
respiration studies and for access to unpublished data.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Biology and Biotechnology, University of Sheffield, P.O. Box 594, Firth Court, Western Bank, Sheffield S10 2TN, United Kingdom. Phone: 44 114 222 4414. Fax: 44 114 272 8697. E-mail:
d.kelly{at}sheffield.ac.uk.
 |
REFERENCES |
| 1.
|
Blamey, J. M., and M. W. W. Adams.
1993.
Purification and characterisation of pyruvate ferredoxin oxidoreductase from the hyperthermophilic archaeon Pyrococcus furiosus.
Biochim. Biophys. Acta
1161:19-27[Medline].
|
| 2.
|
Blamey, J. M., and M. W. W. Adams.
1994.
Characterisation of an ancestral type of pyruvate ferredoxin oxidoreductase from the hyperthermophilic bacterium, Thermotoga maritima.
Biochemistry
33:1000-1007[Medline].
|
| 3.
|
Blaschkowski, H. P.,
G. Neuer,
M. Ludwig-Festl, and J. Knappe.
1982.
Routes of flavodoxin and ferredoxin reduction in Escherichia coli: CoA acylating pyruvate:flavodoxin and NADPH:flavodoxin oxidoreductases participating in the activation of pyruvate formate lyase.
Eur. J. Biochem.
123:563-569[Medline].
|
| 4.
|
Cannon, M.,
F. Cannon,
V. Buchanan-Wollaston,
D. Ally,
A. Ally, and J. Beynon.
1988.
The nucleotide sequence of the nifJ gene of Klebsiella pneumoniae.
Nucleic Acids Res.
16:11379[Free Full Text].
|
| 5.
|
Chalk, P. A.,
A. D. Roberts, and W. M. Blows.
1994.
Metabolism of pyruvate and glucose by intact cells of Helicobacter pylori studied by 13C NMR spectroscopy.
Microbiology
140:2085-2092[Abstract].
|
| 6.
|
Chang, H. T.,
S. W. Marcelli,
A. A. Davison,
P. A. Chalk,
R. K. Poole, and R. J. Miles.
1995.
Kinetics of substrate oxidation by whole cells and cell membranes of Helicobacter pylori.
FEMS Microbiol. Lett.
129:33-38[Medline].
|
| 7.
|
Clayton, C. L.,
N. J. Hughes, and P. A. Chalk.
1994.
Molecular characterisation of a major NADPH dehydrogenase of Helicobacter pylori.
Am. J. Gastroenterol.
89:1293.
|
| 8.
| Clayton, C. L., A. Tay, C. O'Donnell, and P. A. Chalk. 1995. Elucidation of Helicobacter pylori
metabolism by random genome sequencing. Gut 37(Suppl.
1):A67.
|
| 9.
|
Daucher, J. A., and N. R. Krieg.
1995.
Pyruvate:ferredoxin oxidoreductases in Campylobacter species.
Can. J. Microbiol.
41:198-201.
|
| 9a.
| Davison, A. A. (University of Sheffield).
Personal communication.
|
| 10.
| Davison, A. A., D. J. Kelly, P. J. White,
P. A. Chalk, and C. L. Clayton. 1995. Sequencing and
inactivation of a Helicobacter pylori hydrogenase. Gut
37(Suppl. 1):A18.
|
| 11.
|
Docampo, R.,
S. N. J. Moreno, and R. P. Mason.
1987.
Free radical intermediates in the reaction of pyruvate:ferredoxin oxidoreductase in Tritrichomonas foetus hydrogenosomes.
J. Biol. Chem.
262:12417-12420[Abstract/Free Full Text].
|
| 12.
|
Dunn, B. E.,
G. P. Campbell,
G. I. Prez-Perez, and M. J. Blaser.
1990.
Purification and characterization of urease from Helicobacter pylori.
J. Biol. Chem.
265:9464-9469[Abstract/Free Full Text].
|
| 13.
|
Ebbole, D. J., and H. Zalkin.
1987.
Cloning and characterization of a 12 gene cluster from Bacillus subtilis encoding nine enzymes for de novo purine nucleotide synthesis.
J. Biol. Chem.
262:8274-8287[Abstract/Free Full Text].
|
| 14.
|
Edwards, D. I.
1993.
Nitroimidazole drugs action and resistance mechanisms. I. Mechanisms of action.
J. Antimicrob. Chemother.
31:9-20[Free Full Text].
|
| 15.
|
Forman, D.,
D. G. Newell,
F. Fullerton,
J. W. G. Yarnell,
A. R. Stacey,
N. Wald, and F. Sitas.
1991.
Association between Helicobacter pylori infection and risk of gastric cancer: evidence from a prospective investigation.
Br. Med. J.
302:1302-1305.
|
| 16.
|
Glupczinski, Y.
1992.
Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori.
Eur. J. Clin. Microbiol. Infect. Dis.
11:777-781[Medline].
|
| 17.
|
Goodwin, C. S.,
B. J. Marshall,
E. D. Blincow,
D. H. Wilson,
D. Blackbourn, and M. Phillips.
1988.
Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
J. Clin. Pathol.
41:207-210[Abstract/Free Full Text].
|
| 18.
|
Hawkins, C. F.,
A. Borges, and R. N. Perham.
1989.
A common structural motif in thiamin pyrophosphate-binding enzymes.
FEBS Lett.
255:77-82[Medline].
|
| 19.
|
Hoffman, P. S.,
A. Goodwin,
J. Johnsen,
K. Magee, and S. J. O. Veldhuzyen van Zanten.
1996.
Metabolic activities of metronidazole-sensitive and resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance.
J. Bacteriol.
178:4822-4829[Abstract/Free Full Text].
|
| 20.
|
Hughes, N. J.,
P. A. Chalk,
C. L. Clayton, and D. J. Kelly.
1995.
Identification of carboxylation enzymes and characterization of a novel four-subunit pyruvate:flavodoxin oxidoreductase from Helicobacter pylori.
J. Bacteriol.
177:3953-3959[Abstract/Free Full Text].
|
| 21.
|
Kerscher, L., and D. Oesterhelt.
1981.
Purification and properties of two 2-oxoacid:ferredoxin oxidoreductases from Halobacterium halobium.
Eur. J. Biochem.
116:587-594[Medline].
|
| 22.
|
Kletzin, A., and M. W. Adams.
1996.
Molecular and phylogenetic characterization of pyruvate and 2-ketoisovalerate ferredoxin oxidoreductases from Pyrococcus furiosus and pyruvate:ferredoxin oxidoreductase from Thermotoga maritima.
J. Bacteriol.
178:248-257[Abstract/Free Full Text].
|
| 23.
|
Kletzin, A., and M. W. Adams.
1996.
Oxidoreductase-type enzymes and redox proteins involved in fermentative metabolisms of hyperthermophilic archea.
Adv. Protein Chem.
48:101-180[Medline].
|
| 24.
|
Kunow, J.,
D. Linder, and R. K. Thauer.
1995.
Pyruvate:ferredoxin oxidoreductase from the sulfate-reducing Archaeoglobus fulgidus: molecular composition, catalytic properties, and sequence alignments.
Arch. Microbiol.
163:21-28[Medline].
|
| 25.
|
Mai, X. H., and M. W. W. Adams.
1996.
Characterization of a fourth type of 2-keto acid-oxidizing enzyme from a hyperthermophilic archaeon: 2-ketoglutarate ferredoxin oxidoreductase from Thermococcus litoralis.
J. Bacteriol.
178:5890-5896[Abstract/Free Full Text].
|
| 26.
|
Maier, R. J.,
C. Fu,
J. Gilbert,
F. Moshiri,
J. Olsen, and A. G. Plaut.
1996.
Hydrogen uptake hydrogenase in Helicobacter pylori.
FEMS Microbiol. Lett.
141:71-76[Medline].
|
| 27.
|
Majewski, S. I., and C. S. Goodwin.
1988.
Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable variation.
J. Infect. Dis.
157:465-471[Medline].
|
| 28.
|
Mayhew, S. G., and M. L. Ludwig.
1975.
Flavodoxins and electron-transferring flavoproteins, p. 57-118. In
P. D. Boyer (ed.), The enzymes, vol. 12.
Academic Press, New York, N.Y.
|
| 29.
|
Mendz, G. L., and S. L. Hazell.
1991.
Evidence for a pentose-phosphate pathway in Helicobacter pylori.
FEMS Microbiol. Lett.
84:331-336.
|
| 30.
|
Mendz, G. L.,
S. L. Hazell, and B. P. Burns.
1994.
The Entner-Doudoroff pathway in Helicobacter pylori.
Arch. Biochem. Biophys.
312:349-356[Medline].
|
| 31.
|
Parsonnet, J.,
G. D. Friedman,
D. P. Vandersteen,
Y. Chang,
J. H. Vogelman,
N. Orentreich, and R. K. Sibley.
1991.
Helicobacter pylori infection and the risk of gastric carcinoma.
N. Engl. J. Med.
325:1127-1131[Abstract].
|
| 32.
|
Plaga, W.,
F. Lottspeich, and O. Oesterhelt.
1992.
Improved purification, crystallization and primary structure of pyruvate:ferredoxin oxidoreductase from Halobacterium halobium.
Eur. J. Biochem.
205:391-397[Medline].
|
| 33.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbour Press.
|
| 34.
|
Schmitz, O.,
T. Kentemich,
W. Zimmer,
B. Hundeshagen, and H. Bothe.
1993.
Identification of the nifJ gene coding for pyruvate:ferredoxin oxidoreductase in dinitrogen-fixing cyanobacteria.
Arch. Microbiol.
160:62-67[Medline].
|
| 35.
|
Shah, V. K.,
G. Stacey, and W. J. Brill.
1983.
Electron transport to nitrogenase: purification and characterisation of pyruvate:flavodoxin oxidoreductase, the nifJ gene product.
J. Biol. Chem.
258:12064-12068[Abstract/Free Full Text].
|
| 36.
|
Siddiqui, M. A.,
S. Fujiwara, and T. Imanaka.
1997.
Indolepyruvate ferredoxin oxidoreductase from Pyrococcus sp. KOD1 possesses a mosaic structure showing features of various oxidoreductases.
Mol. Gen. Genet.
254:433-439[Medline].
|
| 37.
|
Silver, S., and T. K. Misra.
1988.
Plasmid-mediated heavy metal resistance.
Annu. Rev. Microbiol.
42:717-743[Medline].
|
| 38.
|
Smith, M. A., and D. I. Edwards.
1997.
Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori.
J. Antimicrob. Chemother.
39:347-353[Abstract/Free Full Text].
|
| 39.
|
Stigerwald, V. J.,
G. S. Beckler, and J. N. Reeve.
1990.
Conservation of hydrogenase and polyferredoxin structures in the hyperthermophilic archaebacterium Methanothermus fervidus.
J. Bacteriol.
172:4715-4718[Abstract/Free Full Text].
|
| 40.
|
Tomb, J. F.,
O. White,
A. R. Kerlavage,
R. A. Clayton,
G. G. Sutton,
R. D. Fleischmann,
K. A. Ketchum,
H. P. Klenk,
S. Gill,
B. A. Dougherty,
K. Nelson,
J. Quackenbush,
L. Zhou,
E. F. Kirkness,
S. Peterson,
B. Loftus,
D. Richardson,
R. Dodson,
H. G. Khalak,
A. Glodek,
K. McKenny,
L. M. Fitxegerald,
N. Lee,
M. D. Adams,
E. K. Hickey,
D. E. Berg,
J. D. Gocayne,
T. R. Utterbeck,
J. D. Peterson,
J. M. Kelly,
M. D. Cotton,
J. M. Weidman,
C. Fujii,
C. Bowman,
L. Watthey,
E. Wallin,
M. S. Hayes,
M. Borodovsky,
P. D. Karp,
H. O. Smith,
C. M. Fraser, and J. C. Venter.
1997.
The complete genome sequence of the gastric pathogen Helicobacter pylori.
Nature
387:538-547[Medline].
|
| 41.
|
Trieu-Cuat, P.,
G. Gerbaud,
T. Lambert, and P. Courvalin.
1985.
In vivo transfer of genetic information between Gram-positive and Gram-negative bacteria.
EMBO J.
4:3583-3587[Medline].
|
| 42.
|
Tytgat, G. N. J.,
A. Lee,
D. Y. Graham,
M. F. Dixon, and T. Rokkas.
1993.
The role of infectious agents in peptic ulcer disease.
Gastroenterol. Int.
6:76-89.
|
| 43.
|
Wang, Y., and D. E. Taylor.
1990.
Chloramphenicol resistance in Campylobacter coli nucleotide sequence, expression and cloning vector construct.
Gene
94:23-28[Medline].
|
| 44.
|
Yang, Y. L., and W. B. Whitman.
1994.
Purification and characterisation of pyruvate oxidoreductase from Methanococcus maripaludis, p. 287.
Abstracts of the 94th General Meeting of the American Society for Microbiology 1994.
American Society for Microbiology, Washington, D.C.
|
| 45.
|
Yoon, K. S.,
M. Ishii,
Y. Igarashi, and T. Kodama.
1996.
Purification and characterization of 2-oxoglutarate ferredoxin oxidoreductase from a thermophilic, obligately chemolithoautotrophic bacterium, Hydrogenobacter thermophilus TK-6.
J. Bacteriol.
178:3365-3368[Abstract/Free Full Text].
|
J Bacteriol, March 1998, p. 1119-1128, Vol. 180, No. 5
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.